Temiko Shimada
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case Report.
Journal: JTO clinical and research reports
Published: August 26, 2024
Continuous immunotherapy beyond progression in clinical practice for small cell lung cancer.
Journal: Thoracic cancer
Published: December 03, 2023
Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: December 12, 2018
Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
Journal: Respiratory investigation
Published: April 07, 2015
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 08, 2014
Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 13, 2014
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001).
Journal: Cancer chemotherapy and pharmacology
Published: March 06, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026